# Singmed

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/singmed

- Industry: Medical Devices & Equipment
- Headquarters: Suzhou, China
- Website: www.singmed.cn
- Total disclosed funding: $44M
- Latest round: Series B (Apr 28, 2026)
- Investors on record: 6

## About

Based in Suzhou, China and founded in 2016 by Albert Zhao, Suzhou Singmed Medical Device Science and Technology Ltd., dba Singmed, provides drug delivery solutions for the healthcare industry. The company was established to design and develop high quality, affordable drug delivery devices to enhance clinical efficacy for patients in China.

In April 2026, Singmed raised approximately CNY 300 million in series B funding led by Oriza Holdings with participation from Creacion Ventures, UOB Venture Management, Jolmo Capital, Changshu Jingkai Holdings, Changshu Guofa Venture Capital, and other investors.

Singmed's main products include single-dose capsule DPI (Dry Powder Inhaler) devices, multi-dose blister DPI devices, soft mist inhalation devices and multi-power nasal spray devices. Its products are used in the delivery of asthma, chronic obstructive pulmonary disease (COPD), nasal and brain diseases.

The company’s revenue is generated from manufacturing complex drug delivery devices and drug-device combination products.

The company will use the Series B funding to develop its drug delivery platforms, focusing on pulmonary and nasal delivery systems, and to support further work in device design, engineering, and manufacturing, as well as collaboration with external partners.

## Funding rounds

- Series B, Apr 28, 2026, $44M — UOB Venture Management, Oriza Holdings, Jolmo Capital, Changshu Guofa Venture Capital, Creacion Ventures, Changshu Jingkai Holdings
- Series A, Sep 26, 2022 — Creacion Ventures

## Investors

- Creacion Ventures (https://capitalatlas.ai/funds/creacion-ventures) — Series A, Series B
- UOB Venture Management (https://capitalatlas.ai/funds/uob-venture-management) — Series B
- Oriza Holdings (https://capitalatlas.ai/funds/oriza-holdings) — Series B
- Jolmo Capital (https://capitalatlas.ai/funds/jolmo-capital) — Series B
- Changshu Guofa Venture Capital (https://capitalatlas.ai/funds/changshu-guofa-venture-capital) — Series B
- Changshu Jingkai Holdings — Series B